首页 > 最新文献

Cardiology Plus最新文献

英文 中文
Deciphering the role of autophagy in heart failure 解读自噬在心力衰竭中的作用
Q4 Medicine Pub Date : 2021-04-01 DOI: 10.4103/2470-7511.320324
Amir Ajoolabady, J. Tuomilehto, Gregory H. Lip, D. Klionsky, Jun Ren
Heart failure (HF) refers to a progressive pathological condition when cardiac muscles fail to pump adequate blood supply (cardiac output) to meet the metabolic demand of the body. Among various cellular and molecular mechanisms identified for the onset and progression of HF, autophagy dysregulation is increasingly getting recognized. Autophagy is a natural cellular process that is observed in almost all eukaryotic cells. Autophagy removes damaged/long-lived organelles, protein aggregates, and unwanted cellular compomemts via forming autophagosomes then fusing with lysosomes. Although mild-to-moderate induction of autophagy is deemed cytoprotective and adaptive, excessive or unchecked induction of autophagy can be detrimental and maladaptive. Both adaptive and maladaptive autophagy play a vital role in the pathophysiology of HF. In the current review, we provide an overview of autophagy regulation in HF and possible strategies targeting autophagy for the management of HF.
心力衰竭(HF)是指心肌无法泵出足够的血液供应(心输出量)来满足身体代谢需求时的一种渐进性病理状况。在HF发病和发展的各种细胞和分子机制中,自噬失调越来越被人们所认识。自噬是一种在几乎所有真核细胞中都能观察到的自然细胞过程。自噬通过形成自噬体,然后与溶酶体融合,去除受损/长寿命的细胞器、蛋白质聚集体和不需要的细胞成分。尽管轻度至中度的自噬诱导被认为是细胞保护性和适应性的,但过度或未经检查的自噬诱发可能是有害的和不适应的。适应性和不适应性自噬在HF的病理生理学中都起着至关重要的作用。在目前的综述中,我们概述了HF中的自噬调节以及针对自噬的可能策略。
{"title":"Deciphering the role of autophagy in heart failure","authors":"Amir Ajoolabady, J. Tuomilehto, Gregory H. Lip, D. Klionsky, Jun Ren","doi":"10.4103/2470-7511.320324","DOIUrl":"https://doi.org/10.4103/2470-7511.320324","url":null,"abstract":"Heart failure (HF) refers to a progressive pathological condition when cardiac muscles fail to pump adequate blood supply (cardiac output) to meet the metabolic demand of the body. Among various cellular and molecular mechanisms identified for the onset and progression of HF, autophagy dysregulation is increasingly getting recognized. Autophagy is a natural cellular process that is observed in almost all eukaryotic cells. Autophagy removes damaged/long-lived organelles, protein aggregates, and unwanted cellular compomemts via forming autophagosomes then fusing with lysosomes. Although mild-to-moderate induction of autophagy is deemed cytoprotective and adaptive, excessive or unchecked induction of autophagy can be detrimental and maladaptive. Both adaptive and maladaptive autophagy play a vital role in the pathophysiology of HF. In the current review, we provide an overview of autophagy regulation in HF and possible strategies targeting autophagy for the management of HF.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"92 - 101"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43937007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Anatomical analysis and prognostic assessment of degenerative mitral regurgitation based on a large echocardiography database: Implications for transcatheter edge-to-edge and chordal repair 基于大型超声心动图数据库的退行性二尖瓣返流解剖分析和预后评估:经导管边缘到边缘和脊索修复的意义
Q4 Medicine Pub Date : 2021-04-01 DOI: 10.4103/2470-7511.320322
Q. Jin, W. Pan, Shasha Chen, Lei Zhang, Daxin Zhou, J. Ge
Background and Objectives: The anatomical characteristics of patients with mitral valve prolapse (MVP) and mitral regurgitation (MR) have rarely been investigated demographically to determine the applicability of transcatheter intervention. Therefore, the study objective was to analyze potential candidates and their prognosis. Predictors determining the prognosis were also investigated. Methods: Patients diagnosed with MVP and MR severity of ≥2+ were screened from our echocardiography database from 2010 to 2012. All clinical and echocardiogram information was retrieved from electronic medical records. The endpoint was all-cause mortality analyzed by a proportional hazards model. Results: A total of 1268 patients (mean age 57.50 ± 14.88 years, 47.16% female) with MVP and MR severity of ≥ 2+ were included. Isolated P2 (n = 239, 18.85%) appeared as the most common site of leaflet prolapse. The incidence of MR jet solely from middle scallop (A2 and/or P2) was 31.07% (n = 394). If a nonsignificant jet from other locations was also accepted, the incidence of MR jet derived from mainly the middle scallop (A2 and/or P2) was 52.10% (n = 659). For MVP patients with MR R + 3, the conservative therapy group had higher mortality than the early surgery group (31.45% vs. 5.25%, P < 0.001) after 4.5 ± 1.0 years of follow-up, multiple analysis showed that surgical treatment (hazard ratio [HR]: 0.202, P < 0.001), systolic pulmonary artery pressure of o60 mmHg (HR: 6.816, P < 0.001), age of ≥ 60 years (HR: 3.838, P < 0.001), and pericardial effusion (HR: 1.915, P = 0.003) were independent predictors of all-cause mortality. Conclusions: In patients with MVP, one-fifth leaflet prolapse located solely in P2 and one-half of MR jet derived from the middle scallop were anatomically eligible for transcatheter chordal repair and edge-to-edge repair therapy, respectively. Initial conservative therapy, pericardial effusion, pulmonary hypertension, and advanced age were independent predictors of a higher mortality rate in MVP patients with MR severity of ≥ 3+.
背景和目的:二尖瓣脱垂(MVP)和二尖瓣反流(MR)患者的解剖特征很少被人口学研究来确定经导管干预的适用性。因此,本研究的目的是分析潜在的候选者及其预后。还研究了决定预后的预测因素。方法:从我们的超声心动图数据库中筛选2010年至2012年诊断为MVP且MR严重程度≥2+的患者。所有临床和超声心动图信息都是从电子医疗记录中检索的。终点是通过比例危险模型分析的全因死亡率。结果:共有1268名MVP和MR严重程度≥2+的患者(平均年龄57.50±14.88岁,女性47.16%)被纳入。孤立的P2(n=239,18.85%)是小叶脱垂最常见的部位。仅来自中间扇贝(A2和/或P2)的MR射流发生率为31.07%(n=394)。如果也接受来自其他位置的非显著射流,则主要来自中间扇形(A2和/或P2)的MR射流的发生率为52.10%(n=659)。对于MR R+3的MVP患者,经过4.5±1.0年的随访,保守治疗组的死亡率高于早期手术组(31.45%对5.25%,P<0.001),多项分析显示,手术治疗(危险比[HR]:0.202,P<0.001,心包积液(HR:1.915,P=0.003)是全因死亡率的独立预测因素。结论:在MVP患者中,仅位于P2的五分之一小叶脱垂和来自中间扇形的一半MR射流在解剖学上分别符合经导管脊索修复和边缘到边缘修复治疗的条件。初次保守治疗、心包积液、肺动脉高压和高龄是MR严重程度≥3+的MVP患者较高死亡率的独立预测因素。
{"title":"Anatomical analysis and prognostic assessment of degenerative mitral regurgitation based on a large echocardiography database: Implications for transcatheter edge-to-edge and chordal repair","authors":"Q. Jin, W. Pan, Shasha Chen, Lei Zhang, Daxin Zhou, J. Ge","doi":"10.4103/2470-7511.320322","DOIUrl":"https://doi.org/10.4103/2470-7511.320322","url":null,"abstract":"Background and Objectives: The anatomical characteristics of patients with mitral valve prolapse (MVP) and mitral regurgitation (MR) have rarely been investigated demographically to determine the applicability of transcatheter intervention. Therefore, the study objective was to analyze potential candidates and their prognosis. Predictors determining the prognosis were also investigated. Methods: Patients diagnosed with MVP and MR severity of ≥2+ were screened from our echocardiography database from 2010 to 2012. All clinical and echocardiogram information was retrieved from electronic medical records. The endpoint was all-cause mortality analyzed by a proportional hazards model. Results: A total of 1268 patients (mean age 57.50 ± 14.88 years, 47.16% female) with MVP and MR severity of ≥ 2+ were included. Isolated P2 (n = 239, 18.85%) appeared as the most common site of leaflet prolapse. The incidence of MR jet solely from middle scallop (A2 and/or P2) was 31.07% (n = 394). If a nonsignificant jet from other locations was also accepted, the incidence of MR jet derived from mainly the middle scallop (A2 and/or P2) was 52.10% (n = 659). For MVP patients with MR R + 3, the conservative therapy group had higher mortality than the early surgery group (31.45% vs. 5.25%, P < 0.001) after 4.5 ± 1.0 years of follow-up, multiple analysis showed that surgical treatment (hazard ratio [HR]: 0.202, P < 0.001), systolic pulmonary artery pressure of o60 mmHg (HR: 6.816, P < 0.001), age of ≥ 60 years (HR: 3.838, P < 0.001), and pericardial effusion (HR: 1.915, P = 0.003) were independent predictors of all-cause mortality. Conclusions: In patients with MVP, one-fifth leaflet prolapse located solely in P2 and one-half of MR jet derived from the middle scallop were anatomically eligible for transcatheter chordal repair and edge-to-edge repair therapy, respectively. Initial conservative therapy, pericardial effusion, pulmonary hypertension, and advanced age were independent predictors of a higher mortality rate in MVP patients with MR severity of ≥ 3+.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"102 - 108"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46747175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital heart defects: A morphological approach 先天性心脏缺陷:形态学方法
Q4 Medicine Pub Date : 2021-04-01 DOI: 10.4103/2470-7511.320323
Siew Ho
Congenitally malformed hearts are often perceived as too complex for the general practitioner. By using a descriptive method, each malformed heart can be analyzed systematically without reference to presumptions of what went wrong during cardiac embryogenesis. The basis of this method, systemic segmental approach, is reviewed followed by examples of the common malformations.
对于全科医生来说,先天性畸形的心脏通常被认为太复杂了。通过使用描述性方法,可以系统地分析每个畸形心脏,而无需参考心脏胚胎发生过程中出现问题的假设。这种方法的基础,系统节段法,是回顾,然后是常见的畸形的例子。
{"title":"Congenital heart defects: A morphological approach","authors":"Siew Ho","doi":"10.4103/2470-7511.320323","DOIUrl":"https://doi.org/10.4103/2470-7511.320323","url":null,"abstract":"Congenitally malformed hearts are often perceived as too complex for the general practitioner. By using a descriptive method, each malformed heart can be analyzed systematically without reference to presumptions of what went wrong during cardiac embryogenesis. The basis of this method, systemic segmental approach, is reviewed followed by examples of the common malformations.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"141 - 147"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41673470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dapagliflozin Regulates Cardiac Metabolic Remodeling Partially via Uncoupling Protein 3 in a Nondiabetic Thoracic Aortic Constriction-Induced Mouse Model 在非糖尿病胸主动脉收缩小鼠模型中,达格列净通过解偶联蛋白3部分调节心脏代谢重塑
Q4 Medicine Pub Date : 2021-04-01 DOI: 10.4103/2470-7511.320318
L. Bao, Rongchen Liu, Fangying Yan, Huizhi Fan, Guomin Huang, Xiu-fang Gao, Kun Xie, Yong Li, Hai-ming Shi
Objectives: We aimed to examine the protective effects of dapagliflozin (dapa) on thoracic aortic constriction (TAC)-induced heart failure in a nondiabetic mouse model. More specifically, we determined the effects of dapa on uncoupling protein 3 (UCP3) activation and subsequent metabolic remodeling. Methods: Sixty C57BL/6J mice were divided into six groups for TAC surgery and received different doses of dapa via gavage for 4 weeks. Echocardiography was performed to evaluate cardiac structure and function. Histological and molecular markers of cardiac remodeling and metabolic changes were assessed through staining assays, RT-PCR, western blot, and ELISA. HL-1 cells were used to explore the role of UCP3 in metabolic remodeling through transfection with UCP3 siRNA. Results: Mice that received TAC exhibited elevated heart weight/body weight ratios (HW/BW), left ventricular (LV) hypertrophy, impaired LV ejection fraction, and increased rates of fibrosis and apoptosis, unlike mice that received sham operation. Treatment with dapa after TAC restored HW/BW, improved LV parameters, and reduced fibrosis and apoptosis. dapa changed the expression levels of enzymes involved in glucose and fatty acid (FA) metabolism, such as pyruvate dehydrogenase lipoamide kinase isozyme 4, glucose transporter 4, carnitine palmitoyltransferase-1α, carnitine O-acetyltransferase, carnitine O-octanoyltransferase, acyl-CoA thioesterase 1, acyl-CoA thioesterase 2, peroxisome proliferator-activated receptors α and β, proliferator-activated receptor-gamma coactivator-1α, and UCP3, relative to the levels in mice in the TAC group. UCP3 siRNA reduced the expression of AMP-activated protein kinase and of factors involved in FA oxidation in vitro. Conclusions: Dapa exhibits cardioprotective effects in the model and augments expression of UCP3, which may be involved in metabolic remodeling in the failing heart.
目的:我们旨在研究达格列净(dapa)对非糖尿病小鼠胸主动脉缩窄(TAC)引起的心力衰竭的保护作用。更具体地说,我们确定了dapa对解偶联蛋白3 (UCP3)激活和随后的代谢重塑的影响。方法:将60只C57BL/6J小鼠分为6组进行TAC手术,分别给予不同剂量的dapa灌胃4周。超声心动图评价心脏结构和功能。通过染色、RT-PCR、western blot和ELISA检测心脏重塑和代谢变化的组织学和分子标志物。用HL-1细胞转染UCP3 siRNA,探讨UCP3在代谢重塑中的作用。结果:与接受假手术的小鼠不同,接受TAC的小鼠表现出心脏重量/体重比(HW/BW)升高,左室(LV)肥大,左室射血分数受损,纤维化和凋亡率增加。TAC术后给予dapa治疗可恢复HW/BW,改善LV参数,减少纤维化和细胞凋亡。dapa改变了TAC组小鼠葡萄糖和脂肪酸代谢相关酶的表达水平,如丙酮酸脱氢酶、脂酰胺激酶同功酶4、葡萄糖转运蛋白4、肉碱棕榈酰基转移酶-1α、肉碱o -乙酰转移酶、肉碱o -辛酸转移酶、酰基辅酶a硫酯酶1、酰基辅酶a硫酯酶2、过氧化物酶体增殖物激活受体α和β、增殖物激活受体- γ辅激活因子-1α和UCP3。UCP3 siRNA在体外降低amp活化蛋白激酶和FA氧化相关因子的表达。结论:Dapa在模型中具有心脏保护作用,可增强UCP3的表达,UCP3可能参与衰竭心脏的代谢重塑。
{"title":"Dapagliflozin Regulates Cardiac Metabolic Remodeling Partially via Uncoupling Protein 3 in a Nondiabetic Thoracic Aortic Constriction-Induced Mouse Model","authors":"L. Bao, Rongchen Liu, Fangying Yan, Huizhi Fan, Guomin Huang, Xiu-fang Gao, Kun Xie, Yong Li, Hai-ming Shi","doi":"10.4103/2470-7511.320318","DOIUrl":"https://doi.org/10.4103/2470-7511.320318","url":null,"abstract":"Objectives: We aimed to examine the protective effects of dapagliflozin (dapa) on thoracic aortic constriction (TAC)-induced heart failure in a nondiabetic mouse model. More specifically, we determined the effects of dapa on uncoupling protein 3 (UCP3) activation and subsequent metabolic remodeling. Methods: Sixty C57BL/6J mice were divided into six groups for TAC surgery and received different doses of dapa via gavage for 4 weeks. Echocardiography was performed to evaluate cardiac structure and function. Histological and molecular markers of cardiac remodeling and metabolic changes were assessed through staining assays, RT-PCR, western blot, and ELISA. HL-1 cells were used to explore the role of UCP3 in metabolic remodeling through transfection with UCP3 siRNA. Results: Mice that received TAC exhibited elevated heart weight/body weight ratios (HW/BW), left ventricular (LV) hypertrophy, impaired LV ejection fraction, and increased rates of fibrosis and apoptosis, unlike mice that received sham operation. Treatment with dapa after TAC restored HW/BW, improved LV parameters, and reduced fibrosis and apoptosis. dapa changed the expression levels of enzymes involved in glucose and fatty acid (FA) metabolism, such as pyruvate dehydrogenase lipoamide kinase isozyme 4, glucose transporter 4, carnitine palmitoyltransferase-1α, carnitine O-acetyltransferase, carnitine O-octanoyltransferase, acyl-CoA thioesterase 1, acyl-CoA thioesterase 2, peroxisome proliferator-activated receptors α and β, proliferator-activated receptor-gamma coactivator-1α, and UCP3, relative to the levels in mice in the TAC group. UCP3 siRNA reduced the expression of AMP-activated protein kinase and of factors involved in FA oxidation in vitro. Conclusions: Dapa exhibits cardioprotective effects in the model and augments expression of UCP3, which may be involved in metabolic remodeling in the failing heart.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"109 - 120"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45504774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential diagnosis of PRKAG2 Cardiac syndrome in hypertrophic cardiomyopathy patients of han nationality 汉族肥厚型心肌病患者PRKAG2心脏综合征的鉴别诊断
Q4 Medicine Pub Date : 2021-04-01 DOI: 10.4103/2470-7511.320319
Xuejie Li, Nianwei Zhou, Huiyuan Xie, Wen Liu, C. Pan, Xianghong Shu
Objectives: This study aimed to diversify the spectrum of PRKAG2 variants and explore its clinical features in a Chinese Han population with hypertrophic cardiomyopathy (HCM). Methods: Whole-exome sequencing was performed on 200 patients diagnosed with HCM, and four causative PRKAG2 variants were identified in the probands and their relatives using Sanger sequencing. Their clinical manifestations, laboratory examinations, therapeutic methods, and outcomes were documented and analyzed. Results: Four variants were identified in six probands and seven of their relatives. Left ventricular hypertrophy was present in all probands. Five probands had sinus bradycardia, three had implanted pacemakers (PM), one developed heart failure, two had ventricular preexcitation, and one had atrial fibrillation. Conclusions: PRKAG2 cardiac syndrome (PCS) is a rare autosomal dominant disease characterized by ventricular hypertrophy, preexcitation, and progressive conduction defects, resulting in a high incidence of PM implantation. Genetic testing provides robust information for distinguishing PCS from sarcomeric HCM, which will be beneficial in guiding therapy and improving prognosis.
目的:本研究旨在使PRKAG2变异谱多样化,并探讨其在中国汉族肥厚型心肌病(HCM)人群中的临床特征。方法:对200例诊断为HCM的患者进行全外显子组测序,并使用Sanger测序在先证者及其亲属中鉴定出4种致病性PRKAG2变体。对其临床表现、实验室检查、治疗方法和结果进行了记录和分析。结果:在6名先证者及其7名亲属中发现了4种变异。所有先证者均存在左心室肥大。五名先证者有窦性心动过缓,三名植入了起搏器,一名出现心力衰竭,两名有心室预激,一名有心房颤动。结论:PRKAG2心脏综合征(PCS)是一种罕见的常染色体显性遗传疾病,其特征是心室肥大、预激和进行性传导缺陷,导致PM植入的发生率很高。基因检测为区分PCS和肌性HCM提供了强有力的信息,这将有助于指导治疗和改善预后。
{"title":"Differential diagnosis of PRKAG2 Cardiac syndrome in hypertrophic cardiomyopathy patients of han nationality","authors":"Xuejie Li, Nianwei Zhou, Huiyuan Xie, Wen Liu, C. Pan, Xianghong Shu","doi":"10.4103/2470-7511.320319","DOIUrl":"https://doi.org/10.4103/2470-7511.320319","url":null,"abstract":"Objectives: This study aimed to diversify the spectrum of PRKAG2 variants and explore its clinical features in a Chinese Han population with hypertrophic cardiomyopathy (HCM). Methods: Whole-exome sequencing was performed on 200 patients diagnosed with HCM, and four causative PRKAG2 variants were identified in the probands and their relatives using Sanger sequencing. Their clinical manifestations, laboratory examinations, therapeutic methods, and outcomes were documented and analyzed. Results: Four variants were identified in six probands and seven of their relatives. Left ventricular hypertrophy was present in all probands. Five probands had sinus bradycardia, three had implanted pacemakers (PM), one developed heart failure, two had ventricular preexcitation, and one had atrial fibrillation. Conclusions: PRKAG2 cardiac syndrome (PCS) is a rare autosomal dominant disease characterized by ventricular hypertrophy, preexcitation, and progressive conduction defects, resulting in a high incidence of PM implantation. Genetic testing provides robust information for distinguishing PCS from sarcomeric HCM, which will be beneficial in guiding therapy and improving prognosis.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"132 - 140"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44022035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updated algorithm of chronic total occlusion percutaneous coronary intervention from chronic total occlusion club China 慢性全闭塞经皮冠状动脉介入治疗的更新算法来自中国慢性全闭塞俱乐部
Q4 Medicine Pub Date : 2021-04-01 DOI: 10.4103/2470-7511.320320
J. Ge, L. Ge, Y. Huo, Ji-yan Chen, Wei-min Wang, On Behalf of Chronic Total Occlusion Club
In 2018, the Chronic Total Occlusion Club China (CTOCC) presented a new CTO percutaneous coronary intervention (CTO PCI) algorithm. At the end of 2020, an updated CTOCC algorithm was proposed by this group after the adoption of innovative concepts and novel techniques in CTO PCI. The updated CTOCC algorithm summarizes the contemporary CTO PCI practices in China, in which simultaneous contralateral injection and careful angiographic review, along with strategic changes, are emphasized. Additionally, we provide some new recommendations for techniques such as the “move the cap” and “active greeting” techniques and investment procedures.
2018年,中国慢性全闭塞俱乐部(CTOCC)提出了一种新的CTO经皮冠状动脉介入治疗(CTO PCI)算法。2020年底,该小组在采用CTO PCI的创新概念和新技术后,提出了更新的CTOCC算法。更新后的CTOCC算法总结了中国当代CTO PCI实践,其中强调同时对侧注射和仔细的血管造影检查以及策略变化。此外,我们提供了一些新的技术建议,如“移动上限”和“积极问候”技术和投资程序。
{"title":"Updated algorithm of chronic total occlusion percutaneous coronary intervention from chronic total occlusion club China","authors":"J. Ge, L. Ge, Y. Huo, Ji-yan Chen, Wei-min Wang, On Behalf of Chronic Total Occlusion Club","doi":"10.4103/2470-7511.320320","DOIUrl":"https://doi.org/10.4103/2470-7511.320320","url":null,"abstract":"In 2018, the Chronic Total Occlusion Club China (CTOCC) presented a new CTO percutaneous coronary intervention (CTO PCI) algorithm. At the end of 2020, an updated CTOCC algorithm was proposed by this group after the adoption of innovative concepts and novel techniques in CTO PCI. The updated CTOCC algorithm summarizes the contemporary CTO PCI practices in China, in which simultaneous contralateral injection and careful angiographic review, along with strategic changes, are emphasized. Additionally, we provide some new recommendations for techniques such as the “move the cap” and “active greeting” techniques and investment procedures.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"81 - 87"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47649300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Survey of knowledge on and attitudes toward cardiopulmonary resuscitation and automated external defibrillators in China 中国居民对心肺复苏和自动体外除颤器的知识和态度调查
Q4 Medicine Pub Date : 2021-04-01 DOI: 10.4103/2470-7511.320317
Mingwei Wang, Xin-yan Fu, Wen Wen, Chun-yi Wang, Jie Ni, Jing-jie Jiang, Minjua Wu, Zhao Xu, Yong-Ran Cheng, Meng-yun Zhou, L. Ye, Zhanhui Feng, Juan Chen, Xing-wei Zhang
Objectives: The aim of this study was to determine the current knowledge levels on cardiopulmonary resuscitation and automated external defibrillators of Chinese citizens. Methods: A face-to-face questionnaire survey on the knowledge of and attitudes toward the use of CPR and AEDs during an OHCA event was conducted in three high-traffic train stations in Hangzhou and Taizhou, China. The survey included questions on previous experience with CPR, recognition of cardiac arrest, CPR-related concerns, and AED knowledge. Results: A total of 6268 participants were surveyed about their knowledge of and attitudes toward the use of CPR and AEDs. A total of 5981 valid questionnaires, including 3008 from female respondents (50.2%) and 2973 from male respondents (49.8%), were retrieved. The participants were geographically distributed as follows: 18.5% from western China, 19.5% from central China, and 77.0% from eastern China. The educational level, regular residence, and sex of the respondents, as well as legislative policies, were relevant to the knowledge of and attitudes toward the use of CPR and AEDs for OHCA events. The results showed that men were more active than women in terms of CPR training and implementation, as well as had more knowledge and used AEDs more often. More people in eastern and central China had witnessed CPR performance, would pay for CPR training, and would be willing to perform CPR if there was a related legislative policy. Moreover, educational level was crucial to the knowledge of and attitudes toward the use of CPR and AEDs during OHCA events. Conclusions: Chinese citizens lack CPR and AED knowledge and training compared with people in developed countries. We recommend that the state should increase public awareness of CPR and AEDs in China. Mass education, policy implementation, specialized training, and legislative action should be carried out.
目的:本研究旨在确定中国公民目前对心肺复苏和自动体外除颤器的知识水平。方法:在中国杭州和台州的三个高交通量火车站,对OHCA活动期间使用CPR和AED的知识和态度进行了面对面问卷调查。该调查包括关于以往心肺复苏经验、对心脏骤停的认识、心肺复苏相关问题和AED知识的问题。结果:共有6268名参与者接受了关于他们对CPR和AED使用的知识和态度的调查。共检索到5981份有效问卷,其中3008份来自女性受访者(50.2%),2973份来自男性受访者(49.8%)。参与者的地理分布如下:18.5%来自中国西部,19.5%来自中国中部,77.0%来自中国东部。受访者的教育水平、常住地和性别以及立法政策与对在OHCA活动中使用CPR和AED的知识和态度有关。结果表明,在心肺复苏术的培训和实施方面,男性比女性更积极,而且有更多的知识和更频繁地使用AED。在中国东部和中部,更多的人目睹了心肺复苏术的表现,将支付心肺复苏培训的费用,如果有相关的立法政策,他们将愿意进行心肺复苏。此外,教育水平对OHCA活动期间使用CPR和AED的知识和态度至关重要。结论:与发达国家相比,中国公民缺乏心肺复苏和AED知识和培训。我们建议国家应提高中国公众对心肺复苏术和AED的认识。应开展群众教育、政策执行、专业培训和立法行动。
{"title":"A Survey of knowledge on and attitudes toward cardiopulmonary resuscitation and automated external defibrillators in China","authors":"Mingwei Wang, Xin-yan Fu, Wen Wen, Chun-yi Wang, Jie Ni, Jing-jie Jiang, Minjua Wu, Zhao Xu, Yong-Ran Cheng, Meng-yun Zhou, L. Ye, Zhanhui Feng, Juan Chen, Xing-wei Zhang","doi":"10.4103/2470-7511.320317","DOIUrl":"https://doi.org/10.4103/2470-7511.320317","url":null,"abstract":"Objectives: The aim of this study was to determine the current knowledge levels on cardiopulmonary resuscitation and automated external defibrillators of Chinese citizens. Methods: A face-to-face questionnaire survey on the knowledge of and attitudes toward the use of CPR and AEDs during an OHCA event was conducted in three high-traffic train stations in Hangzhou and Taizhou, China. The survey included questions on previous experience with CPR, recognition of cardiac arrest, CPR-related concerns, and AED knowledge. Results: A total of 6268 participants were surveyed about their knowledge of and attitudes toward the use of CPR and AEDs. A total of 5981 valid questionnaires, including 3008 from female respondents (50.2%) and 2973 from male respondents (49.8%), were retrieved. The participants were geographically distributed as follows: 18.5% from western China, 19.5% from central China, and 77.0% from eastern China. The educational level, regular residence, and sex of the respondents, as well as legislative policies, were relevant to the knowledge of and attitudes toward the use of CPR and AEDs for OHCA events. The results showed that men were more active than women in terms of CPR training and implementation, as well as had more knowledge and used AEDs more often. More people in eastern and central China had witnessed CPR performance, would pay for CPR training, and would be willing to perform CPR if there was a related legislative policy. Moreover, educational level was crucial to the knowledge of and attitudes toward the use of CPR and AEDs during OHCA events. Conclusions: Chinese citizens lack CPR and AED knowledge and training compared with people in developed countries. We recommend that the state should increase public awareness of CPR and AEDs in China. Mass education, policy implementation, specialized training, and legislative action should be carried out.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"121 - 131"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43080853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initiating and secondary mechanisms of hypertension along the time course 高血压的发病机制和继发机制
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.4103/2470-7511.312598
Zhiyi Ma
Due to the difference in drug treatment strategies between the “2020 International Society of Hypertension Global Hypertension Practice Guidelines” and the “Expert consensus on the management of hypertension in the young and middle-aged Chinese population” consensus, I made a hypothesis on hypertension mechanisms. The mechanisms behind hypertension differ between age groups. For instance, the sympathetic nervous system might play more important role young and middle-aged hypertensive patients. In this commentary, hypertension mechanisms were classified into initiation and secondary mechanisms. Thereafter, their quantity-effect relationship was speculated. These helped deepen the understanding of the time association and the crosstalk mechanisms.
由于《2020国际高血压学会全球高血压实践指南》与《中国中青年人群高血压管理专家共识》在药物治疗策略上存在差异,我对高血压机制进行了假设。不同年龄组的高血压发病机制不同。例如,交感神经系统可能在中青年高血压患者中发挥更重要的作用。在这篇评论中,高血压的机制分为起始机制和继发机制。随后,推测了它们的数量效应关系。这有助于加深对时间联想和相声机制的理解。
{"title":"Initiating and secondary mechanisms of hypertension along the time course","authors":"Zhiyi Ma","doi":"10.4103/2470-7511.312598","DOIUrl":"https://doi.org/10.4103/2470-7511.312598","url":null,"abstract":"Due to the difference in drug treatment strategies between the “2020 International Society of Hypertension Global Hypertension Practice Guidelines” and the “Expert consensus on the management of hypertension in the young and middle-aged Chinese population” consensus, I made a hypothesis on hypertension mechanisms. The mechanisms behind hypertension differ between age groups. For instance, the sympathetic nervous system might play more important role young and middle-aged hypertensive patients. In this commentary, hypertension mechanisms were classified into initiation and secondary mechanisms. Thereafter, their quantity-effect relationship was speculated. These helped deepen the understanding of the time association and the crosstalk mechanisms.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"21 - 22"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44428764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioinformatics analysis identifies potential biomarkers for the prediction and treatment of myocardial infarction 生物信息学分析确定了预测和治疗心肌梗死的潜在生物标志物
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.4103/2470-7511.312597
Yu-yao Ji, Siang Wei, R. Xu, Runda Wu, K. Yao, Y. Zou
Objectives: The aim of this study was to identify differentially expressed genes (DEGs) related to myocardial infarction (MI), which may serve as research and therapeutic targets. Methods: MI expression profiles were obtained from the Gene Expression Omnibus (GEO) database. DEGs were screened using GEO2R, and DEGs in multiple datasets were identified using Venn diagrams. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway enrichment analyses were performed using the Database for Annotation, Visualization, and Integrated Discovery v6.8. A protein-protein interaction (PPI) network was constructed using STRING and Cytoscape 3.7.2. Coexpedia was used for gene coexpression network analysis and functional annotation. Results: We identified 50 DEGs in the four datasets, including 29 with important roles in the PPI network. GO functional enrichment analysis revealed the involvement of DEGs in biological processes such as cytokine activation, peptidase inhibition, and chemokine activation. KEGG analysis revealed enrichment in chemokine signaling and cytokine-cytokine receptor interactions. Gene coexpression network analysis identified nine hub genes involved in the occurrence and development of MI including tissue inhibitor of metalloproteinase 1; CD44 antigen; lysyl oxidase; formyl peptide receptor 2; matrix metallopeptidase 3; formyl peptide receptor 1; serine (or cysteine) peptidase inhibitor, clade E, member 1; prostaglandin-endoperoxide synthase 2; and elastin. Conclusions: The hub genes identified may play important roles in MI-related biological processes and represent potential diagnostic and therapeutic targets. Therefore, this study lays a foundation for further exploration of the molecular mechanisms of MI.
目的:本研究旨在鉴定与心肌梗死(MI)相关的差异表达基因(DEGs),作为研究和治疗靶点。方法:从Gene expression Omnibus (GEO)数据库中获取MI表达谱。使用GEO2R筛选deg,并使用维恩图识别多个数据集中的deg。使用Database for Annotation, Visualization, and Integrated Discovery v6.8进行基因本体(GO)和京都基因与基因组百科全书(KEGG)途径富集分析。利用STRING和Cytoscape 3.7.2构建蛋白-蛋白相互作用(PPI)网络。使用Coexpedia进行基因共表达网络分析和功能标注。结果:我们在四个数据集中确定了50个deg,其中29个在PPI网络中起重要作用。氧化石墨烯功能富集分析显示,deg参与生物过程,如细胞因子激活、肽酶抑制和趋化因子激活。KEGG分析显示趋化因子信号和细胞因子-细胞因子受体相互作用富集。基因共表达网络分析鉴定出包括金属蛋白酶组织抑制剂1在内的9个参与心肌梗死发生发展的枢纽基因;CD44抗原;赖氨酰化氧;甲酰基肽受体2;基质金属肽酶3;甲酰基肽受体1;丝氨酸(或半胱氨酸)肽酶抑制剂,分支E,成员1;前列腺素内过氧化物合成酶2;和弹性蛋白。结论:发现的枢纽基因可能在心肌梗死相关的生物学过程中发挥重要作用,具有潜在的诊断和治疗靶点。因此,本研究为进一步探索心肌梗死的分子机制奠定了基础。
{"title":"Bioinformatics analysis identifies potential biomarkers for the prediction and treatment of myocardial infarction","authors":"Yu-yao Ji, Siang Wei, R. Xu, Runda Wu, K. Yao, Y. Zou","doi":"10.4103/2470-7511.312597","DOIUrl":"https://doi.org/10.4103/2470-7511.312597","url":null,"abstract":"Objectives: The aim of this study was to identify differentially expressed genes (DEGs) related to myocardial infarction (MI), which may serve as research and therapeutic targets. Methods: MI expression profiles were obtained from the Gene Expression Omnibus (GEO) database. DEGs were screened using GEO2R, and DEGs in multiple datasets were identified using Venn diagrams. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway enrichment analyses were performed using the Database for Annotation, Visualization, and Integrated Discovery v6.8. A protein-protein interaction (PPI) network was constructed using STRING and Cytoscape 3.7.2. Coexpedia was used for gene coexpression network analysis and functional annotation. Results: We identified 50 DEGs in the four datasets, including 29 with important roles in the PPI network. GO functional enrichment analysis revealed the involvement of DEGs in biological processes such as cytokine activation, peptidase inhibition, and chemokine activation. KEGG analysis revealed enrichment in chemokine signaling and cytokine-cytokine receptor interactions. Gene coexpression network analysis identified nine hub genes involved in the occurrence and development of MI including tissue inhibitor of metalloproteinase 1; CD44 antigen; lysyl oxidase; formyl peptide receptor 2; matrix metallopeptidase 3; formyl peptide receptor 1; serine (or cysteine) peptidase inhibitor, clade E, member 1; prostaglandin-endoperoxide synthase 2; and elastin. Conclusions: The hub genes identified may play important roles in MI-related biological processes and represent potential diagnostic and therapeutic targets. Therefore, this study lays a foundation for further exploration of the molecular mechanisms of MI.","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"48 - 55"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41391187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision medicine in coronary artery disease: Time for implementation into practice 冠状动脉疾病的精准医学:实施实践的时机
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.4103/2470-7511.312600
Yuxiang Dai, J. Ge
{"title":"Precision medicine in coronary artery disease: Time for implementation into practice","authors":"Yuxiang Dai, J. Ge","doi":"10.4103/2470-7511.312600","DOIUrl":"https://doi.org/10.4103/2470-7511.312600","url":null,"abstract":"","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"6 1","pages":"1 - 3"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42431330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Cardiology Plus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1